1. Home
  2. AVD vs LCTX Comparison

AVD vs LCTX Comparison

Compare AVD & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Vanguard Corporation ($0.10 Par Value)

AVD

American Vanguard Corporation ($0.10 Par Value)

HOLD

Current Price

$2.24

Market Cap

72.4M

Sector

Industrials

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

N/A

Current Price

$1.01

Market Cap

301.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AVD
LCTX
Founded
1969
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.4M
301.7M
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
AVD
LCTX
Price
$2.24
$1.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$12.00
$6.25
AVG Volume (30 Days)
311.5K
846.4K
Earning Date
03-16-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
61.11
N/A
EPS
N/A
N/A
Revenue
$515,114,000.00
$14,556,000.00
Revenue This Year
$8.82
$109.40
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
53.24
52 Week Low
$2.03
$1.00
52 Week High
$5.92
$2.09

Technical Indicators

Market Signals
Indicator
AVD
LCTX
Relative Strength Index (RSI) 45.67 37.52
Support Level $2.15 N/A
Resistance Level $2.67 $1.18
Average True Range (ATR) 0.12 0.05
MACD 0.02 -0.01
Stochastic Oscillator 32.08 10.81

Price Performance

Historical Comparison
AVD
LCTX

About AVD American Vanguard Corporation ($0.10 Par Value)

American Vanguard Corp is a United States-based diversified specialty and agricultural products company. The company is a manufacturer of specialty solutions that develops and markets safe synthetic, biological, and biorational products for agricultural, commercial, and consumer uses. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: